QUOTE AND NEWS
Motley Fool  Dec 2  Comment 
Marijuana stocks were hot in 2016 -- but not Insys Therapeutics, Cara Therapeutics, and Arena Pharmaceuticals.
Motley Fool  Nov 8  Comment 
Arena got pummeled by the moody market in October.
Motley Fool  Nov 8  Comment 
Milestone payments from partner Eisai help Arena perform better in Q3 than expected.
Motley Fool  Oct 11  Comment 
An upgrade from a small investment bank sent Arena's shares higher last month.
newratings.com  Oct 3  Comment 
WASHINGTON (dpa-AFX) - Eisai Inc. and Arena Pharmaceuticals, Inc. (ARNA) today announced the availability of Belviq XR, or lorcaserin Hcl, CIV extended-release 20 mg tablets, a new once-daily dosing option that may help some patients achieve and...





 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki